Mary L Graham, NP | |
113 Comanche Rd, Fort Meade, SD 57741-1002 | |
(605) 347-7000 | |
Not Available |
Full Name | Mary L Graham |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 113 Comanche Rd, Fort Meade, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376620823 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | CP000222 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mary L Graham, NP 113 Comanche Rd, Fort Meade, SD 57741-1002 Ph: () - | Mary L Graham, NP 113 Comanche Rd, Fort Meade, SD 57741-1002 Ph: (605) 347-7000 |
News Archive
A landmark study from the Institute of Medicine (IOM) reports that your chance of developing epilepsy at some point in your life is one in 26. Onset is highest in children and older adults. But epilepsy knows no boundaries—it can strike at any age and across all socio-economic levels and ethnicities. There is no known cure and one-third of people with epilepsy have treatment-resistant or refractory epilepsy.
Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50 million. Scientists and clinicians at The University of Texas Health Science Center at Houston can address the diagnosis and treatment of these conditions, as well as the latest advances in research.
While estimates of the overall risk of a thrombotic (blood clot) event recurrence vary, reports on contributing factors are contradictory, according to background information in the article. Knowledge of the risk of a thrombotic event recurrence and its determinants is relevant for clinical policy regarding screening for thrombophilia (increased risk for blood clot), duration of anticoagulant treatment, and treatment strategies in circumstances of increased risk.
The U.S. Food and Drug Administration and several pharmaceutical companies said Tuesday they have reached agreements to alleviate shortages for the drugs methotrexate and Doxil. Methotrexate is used to treat children with a form of leukemia and others with tumors of the breast and lungs. Doxil is used to treat ovarian cancer and multiple myeloma.
› Verified 6 days ago
Kristin Colhoff, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 | |
Sandra Limerick, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 Fax: 605-347-7204 | |
Mrs. Roslyn Grace Robb, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 | |
Mrs. Dania Lynn Phelps, PSYCH NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 180-074-3107 Fax: 605-745-2806 | |
Margery L Wouden, FPNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 Fax: 605-720-7286 | |
Karen Lee Eads, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-720-7000 |